Tumor Markers Flashcards

(45 cards)

1
Q

Produced by epithelial cells of the prostate gland whose function aids in liquefaction of seminal coagulum

A

Prostatic Specific Antigen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

is synthesized in the pancreatic parenchyma and biliary tract.

tumor marker for pancreatic, colorectal, lung and gastric carcinomas

A

CA 19-9

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

CA 19-9 reference range

a. 0-45 u/mL
b. 0-60 u/mL
c. 0-35 u/mL

A

CA 19-9 reference range

a. 0-45 u/mL
b. 0-60 u/mL
c. 0-35 u/mL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

an antigen normally found in breast tissue, used to monitor metastatic breast cancer

A

CA 15-3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

CA 15-3 reference value.

a. less than 40 u/mL
b. less than 45 u/mL
c. less than 35 u/mL
d. less than 30 u/mL

A

CA 15-3 reference value.

a. less than 40 u/mL
b. less than 45 u/mL
c. less than 35 u/mL
d. less than 30 u/mL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

tumor marker for ovarian and endometrial cancer

A

CA-125

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

CA-125 reference range

a. 0-45 units/mL
b. 0-60 units/mL
c. 0-35 units/mL

A

CA-125 reference range

a. 0-45 units/mL
b. 0-60 units/mL
c. 0-35 units/mL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

oncofetal glycoprotein antigen normally synthesized in the liver, yolk sac and gastrointestinal tract of the fetus

tumor marker for liver, testicular and ovarian cancer

A

Alpha-fetoprotein (AFP)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

____ ng/ml fetal serum AFP at 12-15 weeks of gestation.

a. 3-4
b. 2-6
c. 4-7
d.2-3

A

____ ng/ml fetal serum AFP at 12-15 weeks of gestation.

a. 3-4
b. 2-6
c. 4-7
d.2-3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Normal value for AFP in adults

a. < 20 ng/mL
b. < 35 ng/mL
c. < 40 ng/mL
d. < 30 ng/mL

A

Normal value for AFP in adults

a. < 20 ng/mL
b. < 35 ng/mL
c. < 40 ng/mL
d. < 30 ng/mL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

oncofetal glycoprotein antigen normally found in epithelial cells of the fetal GI tract

tumor marker for colorectal cancer and adenocarcinoma of digestive tract

A

Carcinoembryonic Antigen (CEA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Carcinoembryonic Antigen (CEA) normal value.

a. 3-5 ng/mL
b. 3-6 ng/mL
c. 2.5-5 ng/mL
d. 2.3-5 ng/mL

A

Carcinoembryonic Antigen (CEA) normal value.

a. 3-5 ng/mL
b. 3-6 ng/mL
c. 2.5-5 ng/mL
d. 2.3-5 ng/mL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Tumor marker for hydatid form mole, gestational choriocarcinoma and placental-site trophoblastic tumor

A

Beta-Human Chorionic Gonadotrophin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

the antibody that is used to detect the antigen of interest is labeled with an indicator enzyme that enables very small quantities of the antigen of interest to be detected.

A

Enzyme immunoassay (EIA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

is a quantitative method for measurement of antigen or antibody based on the change in electrochemiluminescence (ECL) signal before and after immunoreaction whereby species generated at the electrode undergo a high-energy electron transfer reaction to form excited states that emit light.

A

Electrochemiluminescence immunoassay (ECLIA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

nonspecific, can also be increased in benign conditions such as pregnancy and liver disease, as well
as other types of malignancies such as testicular cancer.

A

AFP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

levels of AFP in high-risk individuals are considered diagnostic of HCC.

A

> 500 ng/mL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

The primary applications of AFP as a tumor marker are
for

A

HCC and nonseminomatous testicular cancer. AFP
is typically used as a marker to monitor therapy, detect
residual tumor, or detect relapse.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

was first defined by a murine monoclonal antibody raised against a serous ovarian carcinoma cell line.10

20
Q

may be elevated in patients with endometriosis, during the first trimester of pregnancy, or during menstruation.

21
Q

commonly used for the detection of small molecules,
such as endocrine metabolites. With respect to tumor markers, it is also used to detect catecholamine metabo-
lites in plasma and urine.

A

High-performance liquid chromatography (HPLC)

22
Q

an abundant serum protein normally synthesized by the fetal liver that is re-expressed in certain types of tumors. This re-expression during malignancy classifies it as a carcinoembryonic protein. it is often elevated in patients with hepatocellular carcinoma (HCC) and germ cell tumors.

23
Q

____ offers improved specific-
ity over CA-125, where it is less frequently elevated in non-malignant conditions, such as endometriosis.

A

HE4 (Human epididymis protein 4)

24
Q

can be detected by immunoassays that use OC125 and M11 antibodies.

25
the average half-life of CA-125 is ____ days.
4.5
26
was discovered in the 1960s and is a prototypical example of an oncofetal antigen; it is expressed during development and then re-expressed in tumors. it is the most widely used tumor marker for colorectal cancer and is also frequently elevated in lung, breast, and gastrointestinal tumors.
CEA
27
high levels of CEA are frequently associated with malignancy,
>10 ng/mL
28
is a large heterogeneous glycoprotein with a molecular weight of approximately 200 kDa. It is part of the immunoglobulin superfamily and is involved in apoptosis, immunity, and cell adhesion.
CEA
29
is indicated in patients with stage II disease (i.e., tumor has spread beyond immediate colon but not to lymph nodes) who have high levels
ADJUVANT THERAPY
30
Although CEA assays historically used polyclonal anti- bodies, these have largely been replaced by the use of
monoclonal anti-CEA antibodies.
31
half-life of CEA is approximately ____ depending on the assay and the individual.
2 to 8 days
32
it may be of value for detecting recurrence of antigen-positive breast and gastrointestinal cancers and medullary thyroid carcinoma, and to aid in the diagnosis of non–small cell lung cancer.
CEA
33
a dimeric hormone normally secreted by tropho- blasts to promote implantation of the blastocyst and the placenta to maintain the corpus luteum through the first trimester of pregnancy.
hCG
34
is not actually cleared by the FDA for use as a tumor marker despite its widespread utility.
hCG
35
It is a prognostic indicator for ovarian cancer, a diagnostic marker for classification of testicular can- cer, and the most useful marker for detection of ges- tational trophoblastic diseases (GTDs).
hCG
36
is a 28-kD glycoprotein produced only in the epithe- lial cells of the acini and ducts of the prostatic ducts in the prostate.
PSA
37
Most of the circulating PSA is complexed to
α1-antichymotrypsin or α2-macroglobulin.
38
Men with ____ and ____ can also have high PSA levels.
benign prostatic hyper- plasia (BPH) and prostatitis
39
>80 prevalence of Prostate cancer in PSA concentration of
>20 ng/mL
40
PSA is measured by ________ which detects both free PSA and PSA complexed with α1-antichymotrypsin but not α2-macroglobulin.
immunoassay
41
? The most common immunoassays used to measure PSA detect which form of the enzyme? a. Total PSA b. Free PSA c. PSA complexed with α1-antichymotrypsin d. PSA complexed with α2-macroglobulin
The most common immunoassays used to measure PSA detect which form of the enzyme? a. Total PSA b. Free PSA **c. PSA complexed with α1-antichymotrypsin** d. PSA complexed with α2-macroglobulin
42
What percentage of women will have invasive can- cer at some time in their life? a. 33% b. 25% c. 50% d. 75%
What percentage of women will have invasive can- cer at some time in their life? **a. 33%** b. 25% c. 50% d. 75%
43
Which of the following enzymes is commonly used as a tumor marker? a. LD b. Lipase c. Aldolase d. Catalase
Which of the following enzymes is commonly used as a tumor marker? **a. LD** b. Lipase c. Aldolase d. Catalase
44
A tumor marker used in the assessment of chorio- carcinoma or hydatidiform mole is a. β-hCG b. CEA c. AFP d. IgG
a. β-hCG
45
A serum PSA is used for all of the following except a. Diagnosis b. Screening c. Monitoring response d. Detecting recurrence
a. Diagnosis